Company thanks the outgoing CEO for his many years of oversight that has accelerated growth in Afinida and Trucept companies.
SAN DIEGO, CA – April 28, 2025 – Norman Tipton, CEO and board member of Afinida (OTC Pink: TREP, “the Company”), today officially announced his retirement, concluding a career spanning several decades in multiple business sectors.
In addition to his most recent title as Chief Executive Officer, Tipton has served as Vice President and General Counsel of Afinida and Trucept, Inc. for the past 10 years and has been a member of Trucept’s Board of Directors since 2013.
Tipton said, “I am deeply grateful for the opportunities I have had working here. I will miss the team but am looking forward to retirement.”
— Outgoing CEO Norman Tipton
Throughout his distinguished professional career, Tipton has held management positions at Fortune 500 companies, has overseen human resources as well as labor relations and negotiations for major organizations, and has served as a noted advisor to several publicly-traded company boards.
“Norman’s been a great colleague and a friend of mine for many years,” said Afinida Chairman, Brian Bonar. “Our team won’t be the same without him and we’ll miss his experienced leadership. We all hope he enjoys his much-deserved retirement,” Bonar added.
The search for Afinida’s new CEO is already underway following the news of Tipton’s departure, and the Company is currently narrowing down a field of potential candidates. While the vetting process is not expected to take long, Afinida will take all necessary steps to ensure the prospective new CEO is the right match to continue Tipton’s vision and legacy.
Afinida continuously innovates and strives to adapt to meet the evolving business needs of its clients while driving sustainable growth and delivering true shareholder value.
Media Contact:
Michael Eslinger
meslinger@afindamkt.com
(858) 463-5867

